港龍中國(06968.HK)1.8億美元票據違約 擬尋求相關債務整體解決方案
港龍中國(06968.HK)公布,一筆已發行年利率9.5%、1.8億美元本金額的票據將於今年11月17日到期,原定於5月18日及11月17日付息,當中5月18日到期應付利息涉約857.62萬美元,其30日利息支付寬限期已過,未支付利息導致該票據違約。
公司於6月19日因未支付利息,收到實益擁有2025年11月票據本金約1.62億美元的主要實益票據持有人通知,指該票據的本金、溢價及應付未付利息為立即到期應付。港龍中國表示,擬繼續與相關票據持有人溝通,尋求相關債務的整體解決方案,以維護所有利害關係人的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.